Scinai Immunotherapeutics (SCNI) EBITDA Margin (2024 - 2026)
Scinai Immunotherapeutics (SCNI) reported EBITDA Margin of 504.5% for Q1 2026, down 23692.0% on a YoY basis from N/an in Q1 2025, and up 57.02% sequentially from 1173.8% in Q2 2025.
Scinai Immunotherapeutics (SCNI) EBITDA Margin (2024 - 2026) Analysis & Trends
Scinai Immunotherapeutics (SCNI) has 3 years of EBITDA Margin data on file, last reported at 504.5% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin fell 23692.0% year-over-year to 504.5%; the trailing twelve-month figure through Mar 2026 stood at 578.54% (changed N/A YoY), and the FY2025 full-year result was 407.91%, up 90485.0% from the prior year.
- EBITDA Margin rose to 504.5% in Q1 2026, from 1173.8% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 267.58% in Q1 2025 to a low of 1440.48% in Q3 2024.
- A 3-year average of 896.98% and a median of 1098.54% in 2024 frame the typical range for EBITDA Margin.
- Peak annual rise in EBITDA Margin reached 23692 bps in 2026, while the deepest fall reached 23692 bps in 2026.
- Tracing SCNI's EBITDA Margin over 3 years: stood at 1098.54% in 2024, then retreated by 7 bps to 1173.8% in 2025, then soared by 57 bps to 504.5% in 2026.
- Business Quant data shows SCNI's EBITDA Margin at 504.5% in Q1 2026, 1173.8% in Q2 2025, and 267.58% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Scinai Immunotherapeutics | 352,860.00 | -3.11 Bn | -1.12 Mn | -504.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -504.50% |
| Jun 30, 2025 | -1,173.80% |
| Mar 31, 2025 | -267.58% |
| Dec 31, 2024 | -1,098.54% |
| Sep 30, 2024 | -1,440.48% |